{"id":"standard-anticoagulation","safety":{"commonSideEffects":[{"rate":"1-10","effect":"Bleeding"},{"rate":"5-15","effect":"Bruising"},{"rate":"0.5-3","effect":"Heparin-induced thrombocytopenia (HIT)"},{"rate":"<1","effect":"Warfarin skin necrosis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Standard anticoagulation typically refers to conventional anticoagulants such as warfarin (vitamin K antagonist) or unfractionated heparin, which work by inhibiting key factors in the coagulation cascade. Warfarin inhibits vitamin K-dependent factors (II, VII, IX, X), while heparin potentiates antithrombin III to inactivate factors IIa and Xa. These agents are used to prevent and treat thromboembolism across multiple clinical settings.","oneSentence":"Standard anticoagulation prevents blood clot formation by inhibiting coagulation cascade factors, reducing thrombotic events.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:09:09.612Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Venous thromboembolism prophylaxis and treatment"},{"name":"Atrial fibrillation for stroke prevention"},{"name":"Mechanical heart valve thromboprophylaxis"},{"name":"Acute coronary syndrome"}]},"trialDetails":[{"nctId":"NCT07499037","phase":"PHASE2","title":"Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO","status":"NOT_YET_RECRUITING","sponsor":"University Hospital Ostrava","startDate":"2027-01","conditions":"Pneumonia, Heart Failure","enrollment":200},{"nctId":"NCT07492901","phase":"NA","title":"Impact of Ligament of Marshall Resection on Atrial Fibrillation Occurrence in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2024-01-11","conditions":"Post Operative Arrythmia","enrollment":220},{"nctId":"NCT05758077","phase":"NA","title":"Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury","status":"RECRUITING","sponsor":"SeaStar Medical","startDate":"2023-04-17","conditions":"Acute Kidney Injury","enrollment":339},{"nctId":"NCT07486739","phase":"NA","title":"Functional And STructural Assesment of the Heart by Artificial Intelligence-enabled Electrocardiogram for the Management of Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2026-05","conditions":"Atrial Fibrillation (AF)","enrollment":1724},{"nctId":"NCT07479147","phase":"","title":"SENIOR: Stroke Prevention in the Elderly by Patent Foramen Ovale closuRe vs Anticoagulation","status":"RECRUITING","sponsor":"Taichung Veterans General Hospital","startDate":"2025-12-16","conditions":"Ischemic Stroke, Embolic Stroke of Undetermined Source, Patent Foramen Ovale (PFO)","enrollment":400},{"nctId":"NCT07487532","phase":"NA","title":"Acupuncture for Preventing Atrial Arrhythmia Recurrence After Ablation","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Zhongshan Hospital","startDate":"2026-04-01","conditions":"Atrial Fibrillation (AF)","enrollment":120},{"nctId":"NCT04996667","phase":"PHASE2","title":"Effect of iNO in Patients With Submassive and Massive PE","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2026-06-01","conditions":"Pulmonary Embolism, Pulmonary Embolism Subacute Massive","enrollment":""},{"nctId":"NCT04077463","phase":"PHASE1","title":"A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-09-04","conditions":"Carcinoma, Non-Small-Cell Lung","enrollment":701},{"nctId":"NCT05900388","phase":"","title":"A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolism (VTE)","status":"NOT_YET_RECRUITING","sponsor":"Bayer","startDate":"2026-09-01","conditions":"Venous Thromboembolism, Children Under 2 Years","enrollment":850},{"nctId":"NCT07477977","phase":"NA","title":"Dose for Reversal of Heparin After Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2026-03-01","conditions":"Open Heart Surgery","enrollment":195},{"nctId":"NCT07467889","phase":"","title":"Impact of CRRT on Serum Carnitine and Micronutrient Levels","status":"COMPLETED","sponsor":"Gulhane Training and Research Hospital","startDate":"2023-01-01","conditions":"Acute Kidney Injury (Nontraumatic), Critical Illness","enrollment":43},{"nctId":"NCT04580563","phase":"NA","title":"Study Assessing Efficacy of Plasmatherapy in Septic Shock-induced Coagulopathy: Feasibility Study","status":"COMPLETED","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-10-22","conditions":"Septic Shock, Coagulopathy, Disseminated Intravascular Coagulation","enrollment":60},{"nctId":"NCT07456085","phase":"PHASE3","title":"Rivaroxaban vs Warfarin in Patients With Mechanical Heart Valves","status":"ENROLLING_BY_INVITATION","sponsor":"Rawalpindi Institute of Cardiology","startDate":"2025-11-13","conditions":"Valvular Heart Disease Patients","enrollment":60},{"nctId":"NCT07469072","phase":"PHASE2","title":"Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)","status":"NOT_YET_RECRUITING","sponsor":"Zhujiang Hospital","startDate":"2026-02-25","conditions":"Continuous Renal Replacement Therapy (CRRT)","enrollment":92},{"nctId":"NCT05047172","phase":"PHASE3","title":"Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-08-02","conditions":"Intracranial Arteriosclerosis, Stroke","enrollment":1683},{"nctId":"NCT06588634","phase":"NA","title":"The PERSEVERE Study","status":"RECRUITING","sponsor":"Inari Medical","startDate":"2024-12-16","conditions":"Pulmonary Embolism, Pulmonary Thromboembolism","enrollment":200},{"nctId":"NCT07458672","phase":"NA","title":"TAVR for Aortic Regurgitation Under TTE Guidance","status":"NOT_YET_RECRUITING","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2026-03-10","conditions":"Aortic Regurgitation, Transcatheter Aortic Valve Replacement (TAVR)","enrollment":30},{"nctId":"NCT07454707","phase":"PHASE3","title":"Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial","status":"NOT_YET_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2026-04","conditions":"Stroke, Ischemic","enrollment":1204},{"nctId":"NCT07441382","phase":"NA","title":"Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-01","conditions":"Atrial Fibrillation (AF), Stroke, Hemorrhage","enrollment":200},{"nctId":"NCT07439731","phase":"","title":"Research on Post-Stroke Anticoagulation Strategies for Atrial Fibrillation Based on Left Atrial Appendage Flow Velocity Measured by Intracardiac Echocardiography (ICE)","status":"COMPLETED","sponsor":"Changhai Hospital","startDate":"2024-01-01","conditions":"Atrial Fibrillation (AF)","enrollment":172},{"nctId":"NCT07438054","phase":"","title":"PRO-AF 52: Monthly Primary-Care 12-Lead ECG Screening for Incident Atrial Fibrillation in Adults Aged ≥65 Years","status":"ENROLLING_BY_INVITATION","sponsor":"Kotyora Family Medicine Health Management and Education Association","startDate":"2026-01-01","conditions":"Atrial Fibrillation (AF)","enrollment":1000},{"nctId":"NCT07432529","phase":"PHASE3","title":"Design and Rationale of the COLT Study","status":"NOT_YET_RECRUITING","sponsor":"Azienda Sanitaria Locale ASL 6, Livorno","startDate":"2026-06-01","conditions":"Venous Thrombosis Deep (Limbs), Post-thrombotic Syndrome, Venous Thromboembolism (VTE)","enrollment":940},{"nctId":"NCT07419802","phase":"","title":"OxiCLEAR (Oxiris Cytokines and Endotoxin Adsorption Rate) Study","status":"RECRUITING","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2026-03-01","conditions":"Sepsis, Septic Shock, Blood Purification","enrollment":29},{"nctId":"NCT07326215","phase":"NA","title":"A Study of the Efficacy and Safety of Extracorporeal Carbon Dioxide Removal Using PrismaLung+","status":"RECRUITING","sponsor":"Vantive Health LLC","startDate":"2025-12-11","conditions":"Acute Respiratory Distress Syndrome, Acute Kidney Injury","enrollment":99},{"nctId":"NCT07404345","phase":"PHASE4","title":"Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)","status":"NOT_YET_RECRUITING","sponsor":"Hospital Civil de Guadalajara","startDate":"2026-03-01","conditions":"Hemodialysis Access Failure, Kidney Disease, End-Stage, Hemodialysis Catheter","enrollment":54},{"nctId":"NCT05498428","phase":"PHASE2","title":"A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-11-11","conditions":"Carcinoma, Non-small-Cell Lung","enrollment":520},{"nctId":"NCT07407790","phase":"NA","title":"The Southern-Norway Post-Stroke Atrial Fibrillation Study","status":"RECRUITING","sponsor":"Sorlandet Hospital HF","startDate":"2026-01-10","conditions":"Atrial Fibrillation (AF), Atrial Fibrillation (Prevention of Stroke), Ischemic Stroke","enrollment":450},{"nctId":"NCT06429332","phase":"PHASE4","title":"International Care Bundle Evaluation in Cerebral Hemorrhage Research","status":"RECRUITING","sponsor":"Region Skane","startDate":"2025-01-07","conditions":"Intracerebral Hemorrhage, Intracerebral Haemorrhage, Intraventricular Hemorrhage","enrollment":3500},{"nctId":"NCT07005024","phase":"PHASE3","title":"DOAC - Dosing Options in AntiCoagulation Prophylaxis","status":"RECRUITING","sponsor":"University of Vermont","startDate":"2025-10-17","conditions":"Cancer, VTE (Venous Thromboembolism)","enrollment":996},{"nctId":"NCT04496362","phase":"PHASE4","title":"Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor Research Institute","startDate":"2018-10-10","conditions":"ECMO, Heparin, Respiratory Failure","enrollment":100},{"nctId":"NCT07374978","phase":"NA","title":"Effect of Thrombolysis on 30-day Mortality in Intermediate High Risk Pulmonary Patients With Low Bleeding Risk","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-07-01","conditions":"Pulmonary Embolism Subacute Massive, Thrombolytic Therapy","enrollment":100},{"nctId":"NCT05156983","phase":"PHASE3","title":"A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery","status":"RECRUITING","sponsor":"Takeda","startDate":"2022-08-24","conditions":"Coagulation Disorder","enrollment":328},{"nctId":"NCT06486181","phase":"PHASE4","title":"Second Line Endovascular Treatment in Acute DVT","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-04-01","conditions":"Deep Venous Thrombosis","enrollment":100},{"nctId":"NCT06909240","phase":"NA","title":"Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DVT-Cph RCT)","status":"RECRUITING","sponsor":"Hvidovre University Hospital","startDate":"2025-11-15","conditions":"Deep Vein Thrombosis (DVT)","enrollment":152},{"nctId":"NCT07236463","phase":"PHASE1, PHASE2","title":"Labile Iron Removal by Adding the Iron Chelator MEX-CD1 to Dialysate in Sepsis-Associated Acute Kidney Injury","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2026-02-01","conditions":"Acute Kidney Injury, Sepsis","enrollment":14},{"nctId":"NCT07352358","phase":"PHASE4","title":"Randomized Trial of Anticoagulation Plus Batroxobin for Acute Cerebral Venous Thrombosis","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2026-01-30","conditions":"Cerebral Venous Thrombosis","enrollment":72},{"nctId":"NCT04273607","phase":"PHASE2, PHASE3","title":"Anticoagulation-free VV ECMO for Acute Respiratory Failure","status":"RECRUITING","sponsor":"Damian Ratano","startDate":"2022-09-01","conditions":"Extracorporeal Membrane Oxygenation Complication","enrollment":40},{"nctId":"NCT07330869","phase":"","title":"Warfarin Effects on Male Fertility After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Città di Lecce Hospital, GVM Care & Research","startDate":"2026-02","conditions":"Male Infertility, Heart Valve Disease","enrollment":90},{"nctId":"NCT06842147","phase":"NA","title":"Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation","status":"RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-03-01","conditions":"Atrial Fibrillation (AF)","enrollment":15360},{"nctId":"NCT07241130","phase":"","title":"Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism","status":"COMPLETED","sponsor":"Ataturk University","startDate":"2025-02-01","conditions":"Pulmonary Embolism Acute","enrollment":120},{"nctId":"NCT05089227","phase":"PHASE2","title":"Efficacy of Prolonged Anticoagulation for Primary Prevention of Venous Thromboembolic Disease in Autoimmune Hemolytic Anemia: a Prospective, Phase II, Randomized, Multicenter Study","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2022-02-03","conditions":"Prolonged Anticoagulation, Venous Thromboembolic Disease, Autoimmune Hemolytic Anemia","enrollment":72},{"nctId":"NCT06138184","phase":"NA","title":"Learning Theory Patient Education for Anticoagulants","status":"NOT_YET_RECRUITING","sponsor":"University of Utah","startDate":"2026-04","conditions":"Knowledge, Attitudes, Practice","enrollment":68},{"nctId":"NCT07284199","phase":"NA","title":"CLEAR Trial: CA330 Cytokine Adsorption Column for Anticoagulant/Antiplatelet Patients in Non-Elective CPB Surgery.","status":"NOT_YET_RECRUITING","sponsor":"Beijing Anzhen Hospital","startDate":"2025-12-15","conditions":"CABG, Aortic Dissection, Valvular Heart Diseases","enrollment":120},{"nctId":"NCT06628778","phase":"PHASE3","title":"Collaborative Risk-stratified Investigation in Teen Inpatients With Critical Illness: Anticoagulation With LMWH in Kids for ThromboProphylaxis (CRITICAL-Kids-TP)","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins All Children's Hospital","startDate":"2026-10-31","conditions":"Venous Thromboembolism (VTE)","enrollment":802},{"nctId":"NCT05646394","phase":"","title":"Registry on Augmented Antithrombotic Treatment Regimens for Patients With Arterial Thrombotic APS","status":"RECRUITING","sponsor":"McMaster University","startDate":"2022-07-01","conditions":"Antiphospholipid Syndrome, Arterial Thrombosis","enrollment":150},{"nctId":"NCT06640114","phase":"NA","title":"Hemoperfusion With Efferon CT for the Treatment of Patients With Severe Psoriasis","status":"COMPLETED","sponsor":"Efferon JSC","startDate":"2024-10-22","conditions":"Psoriasis","enrollment":60},{"nctId":"NCT07243080","phase":"PHASE4","title":"Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention","status":"RECRUITING","sponsor":"Mayo Hospital Lahore","startDate":"2025-10-10","conditions":"Deep Venous Thromboses, Laparotomy Patients","enrollment":212},{"nctId":"NCT05119231","phase":"NA","title":"Pulmonary Vein Isolation vs SHAM-pulmonary Vein Isolation for Symptomatic Relief in Patients With AF","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Leipzig","startDate":"2021-11-12","conditions":"Atrial Fibrillation","enrollment":262},{"nctId":"NCT06966765","phase":"PHASE3","title":"Accelerated vs Standard Approach to Continuous Veno-venous Hemodiafiltration Post-hemoperfusion (ASAP) in Severe Acute Diquat Poisoning","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","startDate":"2027-01-01","conditions":"Diquat Poisoning","enrollment":267},{"nctId":"NCT07194811","phase":"","title":"Stroke of Unknown Cause in Women: The Impact of Long-term Heart Monitoring on Stroke Recurrence","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital, Akershus","startDate":"2016-05","conditions":"Cryptogenic Stroke, Atrial Fibrillation, Implantable Cardiac Monitor","enrollment":1400},{"nctId":"NCT07174505","phase":"NA","title":"Evaluation of the CONDA Stent Retriever in Acute Ischemic Stroke","status":"RECRUITING","sponsor":"Anaconda Biomed S.L.","startDate":"2025-10-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion","enrollment":50},{"nctId":"NCT07174778","phase":"NA","title":"Episodic Future Thinking to Improve Anticoagulant Adherence in Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Jiawen You","startDate":"2025-09-15","conditions":"Atrial Fibrillation (AF)","enrollment":68},{"nctId":"NCT07168278","phase":"PHASE3","title":"Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital of University of Science and Technology of China","startDate":"2025-11-01","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Tenecteplase","enrollment":794},{"nctId":"NCT04298723","phase":"NA","title":"Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.","status":"RECRUITING","sponsor":"Jena University Hospital","startDate":"2020-06-16","conditions":"Intracranial Hemorrhages, Atrial Fibrillation (AF), Atrial Flutter","enrollment":530},{"nctId":"NCT06696079","phase":"NA","title":"Restarting Early Versus Later Anticoagulation for Chronic Subdural Hematoma With Atrial Fibrillation","status":"RECRUITING","sponsor":"Rahul Raj","startDate":"2025-07-07","conditions":"Chronic Subdural Hematoma, Atrial Fibrillation (AF)","enrollment":332},{"nctId":"NCT06591741","phase":"NA","title":"PCA Administration in Prosthetic Joint Infection","status":"NOT_YET_RECRUITING","sponsor":"Dr. Dean Reeves Clinic","startDate":"2026-01","conditions":"Prosthetic Joint Infection","enrollment":100},{"nctId":"NCT05093075","phase":"PHASE2","title":"Therapeutic Plasma Exchange in Septic Shock: A Pilot Study","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2023-06-01","conditions":"Septic Shock","enrollment":80},{"nctId":"NCT07127718","phase":"PHASE2","title":"Preventive Strategies for Early and Late Complications of Leptospirosis","status":"RECRUITING","sponsor":"National Kidney and Transplant Institute, Philippines","startDate":"2024-04-12","conditions":"Leptospirosis","enrollment":678},{"nctId":"NCT05984537","phase":"PHASE4","title":"A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2023-07-01","conditions":"Coronary Microvascular Dysfunction","enrollment":70},{"nctId":"NCT05596175","phase":"NA","title":"Super-Rehab: a Novel Approach to Treat Atrial Fibrillation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal United Hospitals Bath NHS Foundation Trust","startDate":"2023-04-03","conditions":"Atrial Fibrillation, Overweight and Obesity","enrollment":36},{"nctId":"NCT04994158","phase":"","title":"MASCOT Registry of Patients With Myeloproliferative Neoplasms Associated Splanchnic Vein Thrombosis","status":"COMPLETED","sponsor":"Royal Free Hospital NHS Foundation Trust","startDate":"2019-09-01","conditions":"Myeloproliferative Neoplasm, Splanchnic Vein Thrombosis, JAK2 V617","enrollment":238},{"nctId":"NCT07091994","phase":"PHASE4","title":"A Prospective, Multicentre, Randomized Controlled Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy","status":"NOT_YET_RECRUITING","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2025-08-01","conditions":"Ischemic Stroke, Acute, Active Malignancies","enrollment":144},{"nctId":"NCT07081035","phase":"PHASE4","title":"Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-10","conditions":"Advanced Heart Failure, Left Ventricular Assist Devices, Anticoagulation Treatment","enrollment":94},{"nctId":"NCT07064252","phase":"NA","title":"Educational Informed Consent Video in Neurosurgery","status":"COMPLETED","sponsor":"Felix C. Stengel, MD","startDate":"2022-03-01","conditions":"Informed Consent in Neurosurgery","enrollment":171},{"nctId":"NCT05643651","phase":"PHASE4","title":"Rivaroxaban for Children Aged Over 2 Years With Giant Coronary Artery Aneurysms After Kawasaki Disease","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2025-06-01","conditions":"Kawasaki Disease, Coronary Artery Aneurysm","enrollment":100},{"nctId":"NCT06710184","phase":"PHASE4","title":"Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial Infarction","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2025-05-01","conditions":"NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI), Acute Myocardial Infarction (AMI)","enrollment":5076},{"nctId":"NCT07032025","phase":"EARLY_PHASE1","title":"Mechanical Thrombectomy for Acute Pulmonary Embolism","status":"NOT_YET_RECRUITING","sponsor":"RenJi Hospital","startDate":"2025-07-01","conditions":"Acute Pulmonary Embolism","enrollment":200},{"nctId":"NCT05591118","phase":"PHASE3","title":"Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2023-07-17","conditions":"Pulmonary Embolism","enrollment":500},{"nctId":"NCT02387229","phase":"PHASE3","title":"Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF","status":"TERMINATED","sponsor":"Montreal Heart Institute","startDate":"2015-03","conditions":"ATRIAL FIBRILLATION","enrollment":1238},{"nctId":"NCT06868823","phase":"","title":"Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation","status":"RECRUITING","sponsor":"University Hospital, Motol","startDate":"2025-05-01","conditions":"Lung Transplantation, Extracorporeal Membrane Oxygenation (ECMO), Anticoagulants and Bleeding Disorders","enrollment":40},{"nctId":"NCT07006675","phase":"PHASE3","title":"Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial","status":"RECRUITING","sponsor":"Major Extremity Trauma Research Consortium","startDate":"2021-05-26","conditions":"Tibial Fractures, Pain","enrollment":1000},{"nctId":"NCT06955936","phase":"NA","title":"Efferon CT Hemoadsorption for Cardiogenic Shock in Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Efferon JSC","startDate":"2025-04-29","conditions":"Myocardial Infarction, Cardiogenic Shock","enrollment":60},{"nctId":"NCT07002450","phase":"NA","title":"Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Department (LA CLOTTED)","status":"NOT_YET_RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2025-06-15","conditions":"Atrial Fibrillation (AF), Atrial Flutter","enrollment":190},{"nctId":"NCT06998745","phase":"NA","title":"The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-05-01","conditions":"Thrombosis, Venous","enrollment":327},{"nctId":"NCT06523959","phase":"PHASE4","title":"Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial","status":"RECRUITING","sponsor":"Clinical Urology and Epidemiology Working Group","startDate":"2024-06-06","conditions":"Venous Thromboembolism, Bleeding","enrollment":5436},{"nctId":"NCT06699342","phase":"NA","title":"Pacing of Left Bundle Branch Area and Atroventricular Node ablatIon in Patients With Symptomatic Atrial Fibrillation","status":"RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2025-01-27","conditions":"Atrial Fibrillation (AF)","enrollment":50},{"nctId":"NCT03630055","phase":"PHASE3","title":"Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2018-10-03","conditions":"Radial Artery Occlusion","enrollment":1800},{"nctId":"NCT06966947","phase":"","title":"Risk Early Warning Management for Postoperative Hip Fracture Rehabilitation and Delirium Prevention in Elderly Patients","status":"COMPLETED","sponsor":"People's Hospital Affiliated to Hubei University of Medicine","startDate":"2023-01-01","conditions":"Hip Fractures (ICD-10 72.01-72.2)","enrollment":284},{"nctId":"NCT06401863","phase":"NA","title":"Shared Decision for Drug Interactions in Oral Anticoagulation","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-10-01","conditions":"Anticoagulants, Drug Interactions","enrollment":3691},{"nctId":"NCT05431491","phase":"NA","title":"Feasibility of Slow Continuous UltraFiltration For Deresuscitation in Critically Ill Patients","status":"COMPLETED","sponsor":"Belfast Health and Social Care Trust","startDate":"2022-08-12","conditions":"Fluid Overload","enrollment":18},{"nctId":"NCT06925698","phase":"PHASE3","title":"Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease","status":"NOT_YET_RECRUITING","sponsor":"Marmara University","startDate":"2025-04-30","conditions":"Behcet Disease, Behcet Disease and Vascular Involvement, Deep Venous Thromboses","enrollment":110},{"nctId":"NCT06598280","phase":"NA","title":"Same-Day Discharge Versus Overnight Stay Following Pulmonary Vein Isolation for Atrial Fibrillation","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2025-02-20","conditions":"Atrial Fibrillation","enrollment":270},{"nctId":"NCT04903262","phase":"NA","title":"Ultra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS","status":"RECRUITING","sponsor":"University of Bologna","startDate":"2024-12-01","conditions":"Acute Respiratory Distress Syndrome","enrollment":230},{"nctId":"NCT06571149","phase":"PHASE4","title":"Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-03-14","conditions":"Ischemic Stroke","enrollment":906},{"nctId":"NCT04223505","phase":"NA","title":"Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2020-06-26","conditions":"Atrial Fibrillation","enrollment":102},{"nctId":"NCT06844227","phase":"","title":"Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)","status":"RECRUITING","sponsor":"McMaster University","startDate":"2021-12-01","conditions":"Atrial Fibrillation (AF)","enrollment":1780},{"nctId":"NCT06510634","phase":"","title":"Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion","status":"ENROLLING_BY_INVITATION","sponsor":"Tianjin Huanhu Hospital","startDate":"2019-06-01","conditions":"Stroke, Ischemic","enrollment":236},{"nctId":"NCT06833827","phase":"NA","title":"'Thrombectomy in High-Risk Pulmonary Embolism - Device Versus Thrombolysis Netherlands': TORPEDO-NL","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-02","conditions":"Pulmonary Embolism Acute","enrollment":111},{"nctId":"NCT03805048","phase":"NA","title":"PeRcutaneous cOronary Intervention of Native Coronary arTery Versus Venous Bypass Graft in Patients With Prior CABG","status":"ACTIVE_NOT_RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2019-01-22","conditions":"Coronary Artery Disease","enrollment":221},{"nctId":"NCT04437654","phase":"PHASE4","title":"The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2020-07-28","conditions":"Atrial Fibrillation Patients With Intermediate Stroke Risk","enrollment":1800},{"nctId":"NCT03243175","phase":"PHASE3","title":"Avoiding Anticoagulation After IntraCerebral Haemorrhage","status":"RECRUITING","sponsor":"University Hospital, Lille","startDate":"2019-01-17","conditions":"Intracerebral Hemorrhage, Atrial Fibrillation, Microhaemorrhage","enrollment":300},{"nctId":"NCT04362085","phase":"PHASE3","title":"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2020-05-11","conditions":"COVID-19","enrollment":465},{"nctId":"NCT06795698","phase":"PHASE2","title":"The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.","status":"COMPLETED","sponsor":"Hospital Civil de Guadalajara","startDate":"2019-03-01","conditions":"Fractures, Bone, CKD Stage 4, CKD Stage 3","enrollment":61},{"nctId":"NCT06788626","phase":"PHASE3","title":"Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment","status":"NOT_YET_RECRUITING","sponsor":"Wei Hu","startDate":"2025-02","conditions":"Acute Ischemic Stroke, Large Vessel Occlusion, Neuroprotective Drugs","enrollment":390},{"nctId":"NCT06611319","phase":"PHASE3","title":"ENhanced Recovery and ABbreviated LEngth of Anticoagulation for Thromboprophylaxis After Primary Hip Arthroplasty","status":"RECRUITING","sponsor":"Prof. Stavros Konstantinides, MD","startDate":"2024-11-26","conditions":"Hip Arthroplasty, Total, Prevention of Venous Thromboembolism","enrollment":2932},{"nctId":"NCT04936191","phase":"NA","title":"Dynamic Change of Coronary Artery Curvature","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2022-11-18","conditions":"Coronary Artery Disease","enrollment":48},{"nctId":"NCT04505774","phase":"PHASE4","title":"Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE","status":"COMPLETED","sponsor":"Matthew Neal MD","startDate":"2020-09-04","conditions":"Covid19","enrollment":3591},{"nctId":"NCT00291525","phase":"NA","title":"Randomized On-X Anticoagulation Trial","status":"COMPLETED","sponsor":"On-X Life Technologies, Inc.","startDate":"2006-06-06","conditions":"Heart Valve Disease","enrollment":977},{"nctId":"NCT04400981","phase":"NA","title":"Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies","status":"COMPLETED","sponsor":"University of Milano Bicocca","startDate":"2021-08-01","conditions":"Ischemic Stroke","enrollment":80},{"nctId":"NCT06079021","phase":"NA","title":"COOLEY- Study: ACute on ChrOnic Liver FailurE Using the CYtosorb Device","status":"RECRUITING","sponsor":"University Hospital, Antwerp","startDate":"2024-06-08","conditions":"Acute-On-Chronic Liver Failure, Anticoagulant Adverse Reaction, Sarcopenia","enrollment":20}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Standard anticoagulation","genericName":"Standard anticoagulation","companyName":"Faculty Hospital Kralovske Vinohrady","companyId":"faculty-hospital-kralovske-vinohrady","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Standard anticoagulation prevents blood clot formation by inhibiting coagulation cascade factors, reducing thrombotic events. Used for Venous thromboembolism prophylaxis and treatment, Atrial fibrillation for stroke prevention, Mechanical heart valve thromboprophylaxis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}